Endometriosis
📧 Sign up to get email alerts when something new happens for Endometriosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-05-29Clinical Trial Update: Endometriosis and ATR-FTIR Spectroscopy [NA]
This ClinicalTrials.gov entry reports ongoing recruitment for a study sponsored by the Federal University of Espirito Santo evaluating endom…
-
CLINICAL_TRIALS trial_result · 2024-05-20Clinical Trial Update: Compliance and Endometriosis
A clinical trial sponsored by Hospices Civils de Lyon studying endometriosis has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Ulipristal for Endometriosis-related Pelvic Pain [Phase 4]
A Phase 4 clinical trial evaluating ulipristal acetate for endometriosis-related pelvic pain has completed and results have been posted.
-
CLINICAL_TRIALS research · 2024-05-14Clinical Trial Update: Letrozole in Preventing Recurrence of Endometrioma Following Laparoscopic Ovarian Cystectomy [NA]
A clinical trial update indicates recruitment is ongoing for using letrozole to prevent recurrence of endometrioma after laparoscopic ovaria…
-
CLINICAL_TRIALS withdrawal · 2024-05-10Clinical Trial Update: Evaluating Endometriosis With 16α-(18)F-fluoro-17β-estradiol ([F-18] FES) PET/MRI [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating 16α-(18)F-fluoro-17β-estradiol ([F-18] FES) PET/MRI for endometriosis has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Laparoscopic Therapy of Endometrioma: Sclerotherapy vs Cystectomy in Patients With Unfinished Reproductive Plans [NA]
A clinical trial comparing laparoscopic sclerotherapy versus cystectomy for endometrioma in patients with unfinished reproductive plans is c…
-
FDA approval · 2024-04-30FDA Approved: MYFEMBREE — Supplemental Application (Sumitomo Pharma America, Inc)
FDA approved a supplemental application for MYFEMBREE, a relugolix/estradiol hemihydrate/norethindrone acetate combination, expanding its la…
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain (EDELWEISS 6) [Phase 3]
The EDELWEISS 6 Phase 3 extension study evaluating linzagolix for endometriosis-associated pain has completed, with results posted on 2024-0…
-
CLINICAL_TRIALS research · 2024-04-26Clinical Trial Update: Surgical TReatment of Women With Deep ENDometriosis
This clinical trial update describes a study evaluating surgical treatment for deep endometriosis in women, which is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: Degarelix in the Treatment of Endometriosis Recurrence [Phase 3]
Phase 3 trial update on degarelix for treatment of endometriosis recurrence has completed.
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: MicroRNA Activation of LOX-1 Mechanisms in Endometriosis [Phase 4]
A Phase 4 clinical trial investigating microRNA activation of LOX-1 mechanisms in endometriosis was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: Endometrial Preparation in Frozen Embryo Transfer Cycles [Phase 4]
Phase 4 clinical trial update related to endometrial preparation in frozen embryo transfer cycles for IVF.
-
FDA label_change · 2024-01-23FDA Approved: VABRINTY — Supplemental Application (URONOVA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for VABRINTY (leuprolide acetate) from Uronova Pharmaceuticals to modify the drug's labeling.
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: Efficacy of SN132D in Patients With Suspected Endometriosis [Phase 2]
Phase 2 clinical trial evaluating SN132D for suspected endometriosis has completed.
-
FDA approval · 2023-12-04FDA Approved: LUPRON DEPOT — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for LUPRON DEPOT (leuprolide acetate) from AbbVie, updating the product's label under a supplemental…
-
CLINICAL_TRIALS trial_result · 2023-08-18Clinical Trial Update: Randomized Trial Assessing Quinagolide Vaginal Ring for Endometriosis-related Pain [Phase 2]
A Phase 2 randomized trial evaluating a quinagolide vaginal ring for endometriosis-related pain has completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: Efficacy and Safety of BG2109 in Chinese Subjects With Endometriosis [Phase 3]
Phase 3 trial update on BG2109 in Chinese patients with endometriosis, focusing on efficacy and safety for moderate to severe endometriosis-…
-
CLINICAL_TRIALS trial_result · 2023-07-20Clinical Trial Update: SPIRIT EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Endometriosis-Associated Pain [Phase 3]
Phase 3 extension study (SPIRIT EXTENSION) evaluating the efficacy and safety of relugolix in women with endometriosis-associated pain has c…
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Chronic Pain Risk Associated With Menstrual Period Pain [Phase 4]
Phase 4 clinical trial update examining chronic pain risk associated with menstrual period pain has completed and results posted.
-
CLINICAL_TRIALS trial_result · 2023-05-31Clinical Trial Update: Study to Gather Information How Well Three Different Doses of BAY1817080 Given Twice Daily Over 12 Weeks Work in Comparison to an Inactive Pill (Placebo) and Elagolix in Women Suffering From Pain Related to a Condition Where the Tissue That Usually Grows Inside the Womb Grows Outside of the Womb [Phase 2]
Phase 2 trial evaluating BAY1817080 at three doses vs placebo and elagolix in endometriosis; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: Comparisons of the Therapeutic Effects of Dienogest and Danazol on Endometriosis [Phase 3]
Phase 3 clinical trial comparing dienogest versus danazol for endometriosis; results/status not specified.
-
FDA approval · 2023-02-28FDA Approved: LUTRATE DEPOT — Supplemental Application (Avyxa Pharma, LLC)
The FDA approved a supplemental application for LUTRATE DEPOT (leuprolide acetate) submitted by Avyxa Pharma, LLC.
-
CLINICAL_TRIALS trial_result · 2023-02-09Clinical Trial Update: Evaluation of Endometriosis With 18F-fluoroestradiol PET / MRI [Phase 2]
Phase 2 clinical trial evaluating 18F-fluoroestradiol PET/MRI for endometriosis has completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Green Tea Extract for Endometriosis Treatment [Phase 2]
Phase 2 clinical trial evaluating green tea extract for the treatment of endometriosis has been completed.
-
FDA approval · 2023-01-27FDA Approved: MYFEMBREE — Supplemental Application (Sumitomo Pharma America, Inc)
FDA approved a supplemental application for MYFEMBREE (relugolix, estradiol hemihydrate, and norethindrone acetate) submitted by Sumitomo Ph…